Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Removal of Microplastics, Nanoplastics, and PFAS From Human Peripheral Blood Via Double-Filtration Plasmapheresis

NCT07658443 is registered in ClinicalTrials.gov with Proxima Health, Inc. as lead sponsor.

NCT NCT07658443
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07658443 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Removal of Microplastics, Nanoplastics, and PFAS From Human Peripheral Blood Via Double-Filtration Plasmapheresis
Lead sponsor
Proxima Health, Inc.
Phase
Observational
Overall status
Enrolling by invitation
Start date
June 12, 2026
Completion date
September 1, 2026
Enrollment
20 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

double-filtration plasmapheresis, microplastic and nanoplastic particle burden in peripheral blood